250 participants
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-17
- Start Date:
- 2024-06-12
- Completion:
- 2027-12-31
Conditions
- Ovarian Cancer
- Non-small Cell Lung Cancer
Interventions
- DRUG
No Results Yet